Announcements Trials
Browse Landscape

Status

Completed 19Recruiting 10Active not recruiting 5Unknown 3Terminated 2Not yet recruiting 2Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 1COVID-19 1

Interventions

Specimen Handling 7Educational Status 7Cisplatin 7Standard of Care 6Interviews as Topic 6Blood Specimen Collection 6Radiotherapy 5Nivolumab 5Chemoradiotherapy 5Carboplatin 5Surgical Procedures, Operative 4Paclitaxel 4Oxaliplatin 4Fluorouracil 4Drug Therapy 4lenvatinib 3camrelizumab 3Surveys and Questionnaires 3Practice Guidelines as Topic 3Patient Navigation 3Methods 3Magnetic Resonance Spectroscopy 3Magnetic Resonance Imaging 3Lenalidomide 3Gemcitabine 3Fluorodeoxyglucose F18 3Exercise 3Early Intervention, Educational 3Dexamethasone 3Cytarabine 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × OTHER × Telemedicine × Clear all
NCT04357574 2026-02-06

CORONA-SHIELD

Duke University

Enrolling by invitation
1,000 enrolled

COVID-19, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡